MCID: HRD054
MIFTS: 37

Hereditary Neuropathy with Liability to Pressure Palsy

Categories: Rare diseases, Genetic diseases, Neuronal diseases

Aliases & Classifications for Hereditary Neuropathy with Liability to Pressure Palsy

MalaCards integrated aliases for Hereditary Neuropathy with Liability to Pressure Palsy:

Name: Hereditary Neuropathy with Liability to Pressure Palsy 49
Hereditary Liability to Pressure Palsies 69
Polyneuropathy, Familial Recurrent 49
Tomaculous Neuropathy 49
Hnpp 49

Classifications:



Summaries for Hereditary Neuropathy with Liability to Pressure Palsy

NIH Rare Diseases : 49 Hereditary neuropathy with liability to pressure palsy (HNPP) is a disorder that affects peripheral nerves. This condition causes recurrent episodes of numbness, tingling, and/or loss of muscle function (palsy). An episode can last from several minutes to several months, but recovery is usually complete. Repeated incidents, however, can cause permanent muscle weakness or loss of sensation. The most common problem sites involve nerves in wrists, elbows, and knees. Symptoms usually begin during adolescence or early adulthood but may develop anytime from childhood to late adulthood. Symptoms vary in severity; many people never realize they have the disorder, while some people experience prolonged disability. This condition is caused by the loss of one copy of the PMP22 gene or alterations within the gene. It is inherited in an autosomal dominant  manner. Last updated: 7/24/2015

MalaCards based summary : Hereditary Neuropathy with Liability to Pressure Palsy, also known as hereditary liability to pressure palsies, is related to neuropathy, hereditary, with liability to pressure palsies and hereditary neuropathies. An important gene associated with Hereditary Neuropathy with Liability to Pressure Palsy is PMP22 (Peripheral Myelin Protein 22), and among its related pathways/superpathways is Neural Crest Differentiation. The drugs Prednisolone and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and liver.

Wikipedia : 72 Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) is a peripheral neuropathy, a disorder of... more...

Related Diseases for Hereditary Neuropathy with Liability to Pressure Palsy

Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 52)
# Related Disease Score Top Affiliating Genes
1 neuropathy, hereditary, with liability to pressure palsies 33.0 LITAF MPZ PMP22
2 hereditary neuropathies 31.4 MPZ PMP22
3 neuropathy 30.7 MPZ PMP22
4 charcot-marie-tooth disease, demyelinating, type 1a 30.4 MPZ PMP22
5 tooth disease 30.0 LITAF MPZ PMP22
6 charcot-marie-tooth disease 30.0 LITAF MPZ PMP22
7 foot drop 30.0 MPZ PMP22
8 polyneuropathy 29.7 MPZ PMP22
9 chronic inflammatory demyelinating polyradiculoneuropathy 29.7 MPZ PMP22
10 polyradiculoneuropathy 29.6 MPZ PMP22
11 pelizaeus-merzbacher disease 29.6 MPZ PMP22
12 mononeuropathy of the median nerve, mild 11.7
13 plexopathy 10.4
14 carpal tunnel syndrome 10.3
15 amyotrophy, hereditary neuralgic 10.3
16 episodic pain syndrome, familial, 1 10.3
17 amyotrophic neuralgia 10.3
18 amyotrophic lateral sclerosis 1 10.2
19 lateral sclerosis 10.2
20 blood group, i system 10.1
21 schwannomatosis 1 10.1
22 oculopharyngeal muscular dystrophy 10.1
23 metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration 10.1
24 diabetes mellitus 10.1
25 sciatic neuropathy 10.1
26 mononeuropathy 10.1
27 bell's palsy 10.1
28 brachial plexus neuropathy 10.1
29 demyelinating polyneuropathy 10.1
30 muscular atrophy 10.1
31 influenza 10.1
32 muscular dystrophy 10.1
33 myoclonus 10.1
34 charcot-marie-tooth neuropathy type 1 9.8 MPZ PMP22
35 charcot-marie-tooth disease, demyelinating, type 1f 9.8 MPZ PMP22
36 congenital hypomyelination neuropathy 9.8 MPZ PMP22
37 charcot-marie-tooth disease, demyelinating, type 1b 9.8 MPZ PMP22
38 charcot-marie-tooth disease, axonal, type 2b 9.7 MPZ PMP22
39 roussy-levy hereditary areflexic dystasia 9.7 MPZ PMP22
40 motor peripheral neuropathy 9.7 MPZ PMP22
41 charcot-marie-tooth disease, demyelinating, type 1d 9.7 MPZ PMP22
42 guillain-barre syndrome 9.7 MPZ PMP22
43 neuritis 9.6 MPZ PMP22
44 peripheral nervous system disease 9.6 MPZ PMP22
45 diabetic neuropathy 9.6 MPZ PMP22
46 neuromuscular disease 9.6 MPZ PMP22
47 charcot-marie-tooth disease, axonal, type 2e 9.4 MPZ PMP22
48 charcot-marie-tooth disease, demyelinating, type 1c 9.4 LITAF MPZ PMP22
49 charcot-marie-tooth disease and deafness 9.4 LITAF MPZ PMP22
50 hypertrophic neuropathy of dejerine-sottas 9.4 LITAF MPZ PMP22

Graphical network of the top 20 diseases related to Hereditary Neuropathy with Liability to Pressure Palsy:



Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy

Symptoms & Phenotypes for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs & Therapeutics for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs for Hereditary Neuropathy with Liability to Pressure Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 201)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
2
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 137-58-6 3676
3
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
5
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
6
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
7
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
8
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
9
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 124-94-7 31307
10
Ropivacaine Approved Phase 4 84057-95-4 175805 71273
11
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3 56-12-2 119
12
Ibuprofen Approved Phase 4,Phase 2 15687-27-1 3672
13
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
14
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
15
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
16
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 2 76-42-6 5284603
17
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 68-26-8, 11103-57-4 445354
18
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 59-30-3 6037
19 tannic acid Approved, Nutraceutical Phase 4
20 Prednisolone acetate Phase 4,Phase 2,Phase 3
21 Analgesics Phase 4,Phase 3,Phase 2
22 glucocorticoids Phase 4,Phase 3,Phase 2
23 Respiratory System Agents Phase 4,Phase 3
24 Methylprednisolone acetate Phase 4,Phase 2,Phase 3
25 Methylprednisolone Hemisuccinate Phase 4,Phase 2,Phase 3
26 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
27 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
28 Gastrointestinal Agents Phase 4,Phase 2,Phase 3
29 Neuroprotective Agents Phase 4,Phase 2,Phase 3
30 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Tranquilizing Agents Phase 4,Phase 3,Phase 2
32 Analgesics, Non-Narcotic Phase 4,Phase 2
33 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
34 Hormone Antagonists Phase 4,Phase 3,Phase 2
35 Anesthetics, Local Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
36 Hormones Phase 4,Phase 3,Phase 2
37 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
39 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
40 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
41 Anti-Asthmatic Agents Phase 4,Phase 3
42 Anticonvulsants Phase 4,Phase 3
43 Antiemetics Phase 4,Phase 2,Phase 3
44 Antimanic Agents Phase 4,Phase 3
45 Prednisolone hemisuccinate Phase 4,Phase 2,Phase 3
46 Prednisolone phosphate Phase 4,Phase 2,Phase 3
47 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
48 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2
49 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1
50 Psychotropic Drugs Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 252)

# Name Status NCT ID Phase Drugs
1 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
2 Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome Completed NCT02652390 Phase 4 Methylprednisolone 80 mg;Methylprednisolone 40 mg
3 Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries Completed NCT02313675 Phase 4 Acetaminophen;Ketorolac Tromethamine;Saline
4 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
5 Bupivacaine Versus Lidocaine Local Anesthesia Completed NCT01751347 Phase 4 Bupivacaine;Lidocaine
6 Length of Post Operative Dressing After Carpal Tunnel Release Completed NCT01310218 Phase 4
7 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
8 Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters Completed NCT00678314 Phase 4 Ropivacaine 0.2%;Ropivacaine 0.75%;Normal saline
9 Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia Completed NCT00851513 Phase 4 Lidocaine;Depmedrol
10 Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome Completed NCT00277563 Phase 4
11 Narcotic vs. Non-narcotic Pain Study Protocol Recruiting NCT01974609 Phase 4 Narcotic;non-narcotic
12 Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration Active, not recruiting NCT03196817 Phase 4 betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%
13 Injection Versus Splinting in Carpal Tunnel Syndrome Active, not recruiting NCT02038452 Phase 4 Depo-Medrone
14 Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Enrolling by invitation NCT02029235 Phase 4 Acetaminophen/Hydrocodone;Acetaminophen/Ibuprofen
15 Preoperative Antibiotics for Carpal Tunnel Release Surgery Not yet recruiting NCT03432858 Phase 4 Vancomycin;Cefazolin;Saline Solution
16 Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery Terminated NCT01588158 Phase 4 Acetaminophen;Vicodin
17 Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain Withdrawn NCT02748395 Phase 4 Triamcinolone;Lidocaine
18 Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Unknown status NCT01289704 Phase 2, Phase 3
19 Carpal Tunnel Syndrome Release Using PSU Retractor Unknown status NCT01017471 Phase 3
20 High Dose Ascorbic Acid Treatment of CMT1A Completed NCT00484510 Phase 2, Phase 3 Ascorbic acid (Vitamin C);placebo
21 Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Completed NCT02141035 Phase 2, Phase 3 Acetyl-l-carnitine;placebo
22 Sonographic Examination Cubital Tunnel Release Completed NCT02739945 Phase 3
23 Sonography-guided Steroid Injection for Carpal Tunnel Syndrome Completed NCT02575729 Phase 3 betamethasone
24 Preoperative Gabapentine for Carpal Tunnel Completed NCT01632215 Phase 3 Gabapentine
25 Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia Completed NCT02604186 Phase 2, Phase 3
26 Steroid Injection Treatment of Carpal Tunnel Syndrome Completed NCT00806871 Phase 2, Phase 3 Methylprednisolone 40 mg;Methylprednisolone 80 mg;Sodium chloride
27 Gabapentin for Carpal Tunnel Syndrome Completed NCT00137735 Phase 3 Gabapentin
28 Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Completed NCT00007020 Phase 3 Cholic Acids
29 Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Recruiting NCT03023540 Phase 3 PXT3003
30 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
31 Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Active, not recruiting NCT02579759 Phase 3 PXT3003 dose 1;PXT3003 dose 2;placebo
32 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Not yet recruiting NCT03184584 Phase 2, Phase 3 PBI-4050
33 Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome Not yet recruiting NCT02870673 Phase 2, Phase 3 SHINCORT;XYLOCAINE
34 Erythropoietin Spinal Cord Compression Randomized Trial Terminated NCT00220675 Phase 2, Phase 3 Erythropoietin infusion
35 NeuroPath Comparative Validation Study Plan Terminated NCT00393549 Phase 3
36 A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Terminated NCT00209560 Phase 3 fospropofol disodium
37 Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome Terminated NCT00266214 Phase 3 lidocaine patch 5%
38 Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome Unknown status NCT02739217 Phase 2 PBI-4050
39 Minocycline to Reduce Pain After Carpal Tunnel Release Unknown status NCT02051296 Phase 2 Minocycline;placebo
40 Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5 Unknown status NCT02314208 Phase 2 Xenbilox;Tahor
41 Carpal Tunnel Syndrome and Static Magnetic Field Therapy Unknown status NCT00521495 Phase 2
42 Carpal Tunnel Syndrome Treated With 830nm Diode Laser Unknown status NCT00514462 Phase 1, Phase 2
43 Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Completed NCT00541164 Phase 1, Phase 2 Coenzyme Q10
44 Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Completed NCT02561702 Phase 2 Mexiletine
45 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed NCT01401257 Phase 2 PXT3003 Low dose;PXT3003 Intermediate Dose;PXT3003 High Dose
46 Ascorbic Acid Treatment in CMT1A Trial (AATIC) Completed NCT00271635 Phase 2 Placebo;ascorbic acid
47 The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome Completed NCT00634738 Phase 1, Phase 2
48 L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 Completed NCT01733407 Phase 1, Phase 2 L-serine;placebo
49 Comparison of Effect of Anterior Subcutaneous and Submuscular Transposition on Cubital Tunnel Syndrome Completed NCT01109901 Phase 2
50 Treatment of Thoracic Outlet Syndrome (TOS) With Botox Completed NCT00444886 Phase 2 Botulinum Toxin Type A injection (BOTOX);Botulinum Toxin Type A injection (BOTOX)

Search NIH Clinical Center for Hereditary Neuropathy with Liability to Pressure Palsy

Genetic Tests for Hereditary Neuropathy with Liability to Pressure Palsy

Anatomical Context for Hereditary Neuropathy with Liability to Pressure Palsy

MalaCards organs/tissues related to Hereditary Neuropathy with Liability to Pressure Palsy:

38
Testes, Skin, Liver, Heart, Spinal Cord, Brain

Publications for Hereditary Neuropathy with Liability to Pressure Palsy

Articles related to Hereditary Neuropathy with Liability to Pressure Palsy:

(show top 50) (show all 203)
# Title Authors Year
1
Spinobulbar muscular atrophy combined with atypical hereditary neuropathy with liability to pressure palsy. ( 29137918 )
2018
2
Intravenous Immunoglobulin in Treatment of Hereditary Neuropathy With Liability to Pressure Palsy. ( 28221308 )
2017
3
Acute Demyelinating Polyneuropathy as Presentation of Hereditary Neuropathy With Liability to Pressure Palsies in a Patient Who Exercised Regularly in the Army. ( 28538254 )
2017
4
Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria. ( 28407266 )
2017
5
Hereditary neuropathy with liability to pressure palsy (HNPP): report of a family with a new point mutation in PMP22 gene. ( 29078790 )
2017
6
Muscle training-induced bilateral brachial plexopathy in an adolescent with sporadic hereditary neuropathy with liability to pressure palsies. ( 28948078 )
2017
7
Characterisation of pain in people with hereditary neuropathy with liability to pressure palsy. ( 29079893 )
2017
8
The broad clinical spectrum of hereditary neuropathy with liability to pressure palsy (HNPP). ( 26982983 )
2016
9
Hereditary neuropathy with liability to pressure palsy presenting as a bilateral brachial plexopathy. ( 26874568 )
2016
10
[Molecular genetic diagnosis and clinical features of hereditary neuropathy with liability to pressure palsies in Belarusian patients]. ( 26977628 )
2016
11
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. ( 27749933 )
2016
12
Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion. ( 26982985 )
2016
13
Compression of Root Level in a Patient with Hereditary Neuropathy with Liability to Pressure Palsy Diagnosed by Magnetic Resonance Imaging: A Case Report. ( 27149588 )
2016
14
An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP). ( 26187721 )
2015
15
Proximal arm weakness is the most common presentation in young Korean soldiers diagnosed as having hereditary neuropathy with liability to pressure palsy (HNPP). ( 26462743 )
2015
16
Mutational analysis of Greek patients with suspected hereditary neuropathy with liability to pressure palsies (HNPP): a 15-year experience. ( 26110377 )
2015
17
Partial Gene Deletions of PMP22 Causing Hereditary Neuropathy with Liability to Pressure Palsies. ( 25506001 )
2014
18
Characteristic features of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy in soldiers. ( 25175852 )
2014
19
Hereditary neuropathy with liability to pressure palsies presenting with sciatic neuropathy. ( 25326571 )
2014
20
Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation. ( 24239057 )
2014
21
Hereditary Neuropathy with Liability to Pressure Palsy Presenting as an Acute Brachial Plexopathy: A Lover's Palsy. ( 25685136 )
2014
22
Does hereditary neuropathy with liability to pressure palsy predispose to schwannomatosis? ( 25324890 )
2014
23
Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies. ( 24752454 )
2014
24
Ultrasonographic findings in hereditary neuropathy with liability to pressure palsies. ( 25005138 )
2014
25
Pain in hereditary neuropathy with liability to pressure palsy: An association with fibromyalgia syndrome? ( 25042093 )
2014
26
Clinical, electrophysiological, and molecular findings in early onset hereditary neuropathy with liability to pressure palsy. ( 24668782 )
2014
27
Sonographic evaluation of the peripheral nerves in hereditary neuropathy with liability to pressure palsies: a case report. ( 24639934 )
2014
28
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. ( 24646194 )
2014
29
Overlap Phenotype between CMT1A and Hereditary Neuropathy with Liability to Pressure Palsies Caused by the Novel Small In-frame Deletion c.407_418del12 in PMP22 Gene. ( 25265422 )
2014
30
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination. ( 24146347 )
2013
31
Bell's palsy and hereditary neuropathy with liability to pressure palsy (HNPP): is there a common genetic background? ( 23635862 )
2013
32
Hereditary neuropathy with liability to pressure palsy: two cases of difficult diagnosis. ( 23965407 )
2013
33
Hereditary Neuropathy with Liability to Pressure Palsy: global neuropathy after tourniquet use. ( 24080438 )
2013
34
Hereditary neuropathy with liability to pressure palsy: a recurrent and bilateral foot drop case report. ( 24251057 )
2013
35
Comments on 'hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large chinese family'. ( 24192759 )
2013
36
Hereditary neuropathy with liability to pressure palsy: fulminant radicular dysfunction during anterolateral lumbar interbody fusion. ( 23881104 )
2013
37
Hereditary neuropathy with liability to pressure palsy presenting with hand drop in a young child. ( 22953141 )
2012
38
Massive indoor cycling-induced rhabdomyolysis in a patient with hereditary neuropathy with liability to pressure palsy. ( 23240383 )
2012
39
Hereditary neuropathy with liability to pressure palsy: a brief review with a case report. ( 22023293 )
2012
40
Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy. ( 22520972 )
2012
41
Hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family. ( 23147806 )
2012
42
A novel small deletion in PMP22 causes a mild hereditary neuropathy with liability to pressure palsies phenotype. ( 22190321 )
2012
43
Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. ( 22037956 )
2012
44
Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy. ( 22098098 )
2012
45
Sonographic features in hereditary neuropathy with liability to pressure palsies. ( 22581553 )
2012
46
Two cases of elderly-onset hereditary neuropathy with liability to pressure palsy manifesting bilateral peroneal nerve palsies. ( 23185166 )
2012
47
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. ( 23279340 )
2012
48
Hereditary neuropathy with liability to pressure palsies. Diagnosis in the first family (1947) confirmed. ( 23279343 )
2012
49
Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients. ( 25337104 )
2012
50
Hereditary neuropathy with liability to pressure palsies occurring during military training. ( 22545374 )
2012

Variations for Hereditary Neuropathy with Liability to Pressure Palsy

Copy number variations for Hereditary Neuropathy with Liability to Pressure Palsy from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 106962 17 10700000 16000000 Copy number Hereditary neuropathy with liability to pressure palsy

Expression for Hereditary Neuropathy with Liability to Pressure Palsy

Search GEO for disease gene expression data for Hereditary Neuropathy with Liability to Pressure Palsy.

Pathways for Hereditary Neuropathy with Liability to Pressure Palsy

Pathways related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.63 MPZ PMP22

GO Terms for Hereditary Neuropathy with Liability to Pressure Palsy

Cellular components related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 lysosome GO:0005764 8.62 LITAF MPZ

Biological processes related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chemical synaptic transmission GO:0007268 8.96 MPZ PMP22
2 myelination GO:0042552 8.62 MPZ PMP22

Sources for Hereditary Neuropathy with Liability to Pressure Palsy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....